Literature DB >> 26971851

Carcinoid heart disease: Diagnosis and management.

Sushil A Luis1, Patricia A Pellikka2.   

Abstract

Hedinger syndrome refers to carcinoid valvular heart disease. The disease is believed to be triggered by vasoactive substances that result in valvular fibrosis. It classically occurs in patients with metastatic carcinoid and preferentially involves the right sided cardiac valves. Affected valves become thickened and retracted, exhibiting regurgitation and sometimes, stenosis. Echocardiography is recommended in patients with carcinoid syndrome and a follow up study is advisable in those who develop a murmur or other symptoms or signs of valvular heart disease. For appropriately selected patients, valve replacement surgery appears to improve outcomes.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hedinger syndrome; carcinoid; echocardiography; valves

Mesh:

Substances:

Year:  2015        PMID: 26971851     DOI: 10.1016/j.beem.2015.09.005

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  15 in total

Review 1.  Surgical Treatment of Small Intestinal Neuroendocrine Tumors G1/G2.

Authors:  Andreas Selberherr; Martin B Niederle; Bruno Niederle
Journal:  Visc Med       Date:  2017-10-06

Review 2.  Carcinoid-syndrome: recent advances, current status and controversies.

Authors:  Tetsuhide Ito; Lingaku Lee; Robert T Jensen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-02       Impact factor: 3.243

Review 3.  The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors.

Authors:  Jonathan R Strosberg; Thorvardur R Halfdanarson; Andrew M Bellizzi; Jennifer A Chan; Joseph S Dillon; Anthony P Heaney; Pamela L Kunz; Thomas M O'Dorisio; Riad Salem; Eva Segelov; James R Howe; Rodney F Pommier; Kari Brendtro; Mohammad A Bashir; Simron Singh; Michael C Soulen; Laura Tang; Jerome S Zacks; James C Yao; Emily K Bergsland
Journal:  Pancreas       Date:  2017-07       Impact factor: 3.327

Review 4.  Multilayered heterogeneity as an intrinsic hallmark of neuroendocrine tumors.

Authors:  Sergio Pedraza-Arévalo; Manuel D Gahete; Emilia Alors-Pérez; Raúl M Luque; Justo P Castaño
Journal:  Rev Endocr Metab Disord       Date:  2018-06       Impact factor: 6.514

Review 5.  Quadruple Valve Replacement for Carcinoid Heart Disease.

Authors:  Syed Saleem Mujtaba; Stephen Clark
Journal:  Braz J Cardiovasc Surg       Date:  2018 Jul-Aug

Review 6.  Management of Small Bowel Neuroendocrine Tumors.

Authors:  Aaron T Scott; James R Howe
Journal:  J Oncol Pract       Date:  2018-08       Impact factor: 3.714

Review 7.  Valvular Disorders in Carcinoid Heart Disease.

Authors:  Shi-Min Yuan
Journal:  Braz J Cardiovasc Surg       Date:  2016 Sep-Oct

Review 8.  Carcinoid heart disease: a guide for screening and timing of surgical intervention.

Authors:  E A Hart; T A Meijs; R C A Meijer; K M Dreijerink; M E Tesselaar; C A de Groot; G D Valk; S A J Chamuleau
Journal:  Neth Heart J       Date:  2017-09       Impact factor: 2.380

Review 9.  Carcinoid syndrome: update on the pathophysiology and treatment.

Authors:  Anezka C Rubin de Celis Ferrari; João Glasberg; Rachel P Riechelmann
Journal:  Clinics (Sao Paulo)       Date:  2018-08-20       Impact factor: 2.365

10.  Carcinoid heart disease revealed by cyanosis with both right and left valvular involvement: a case report.

Authors:  Khadija Khay; Salim Arous; Tarik Bentaoune; Abdenasser Drighil; Rachida Habbal
Journal:  J Med Case Rep       Date:  2018-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.